Product Information
POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0998 per EA under NDC 63304007801. Its NADAC has been published 343 times since Mar 11, 2020.
FDA first approved this application on Mar 17, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304007801
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208864FDA Approved
3/17/2017
TE Code
AB
On Market Since
1/2/2020
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 343 times since Mar 11, 2020, and over the history we have for it it has declined 60.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0998 per EA |
|---|---|
| All-time high | $0.3584 (Aug 12, 2020) |
| All-time low | $0.0914 (Jul 22, 2026) |
| 52-week high | $0.1336 |
| 52-week low | $0.0914 |
| Median price | $0.1574 |
| Average price | $0.1823 |
| Largest weekly change | -44.0% (Nov 23, 2022) |
| Weeks tracked | 343 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
POTASSIUM CHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.0998 per EA (NDC 63304007801), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 60.4%. It has been tracked across 343 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?
Since Mar 11, 2020, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.0914 (Jul 22, 2026) to a high of $0.3584 (Aug 12, 2020), with a median of $0.1574 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 8 MEQ CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?
POTASSIUM CL ER 8 MEQ CAPSULE (NDC 63304007801) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.